Arax Advisory Partners’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.1K Buy
27,604
+27,555
+56,235% +$102K ﹤0.01% 2915
2026
Q1
$217 Hold
49
﹤0.01% 3524
2025
Q4
$310 Buy
+49
New +$375 ﹤0.01% 3670
2025
Q2
Sell
-26
Closed -$508 3079
2025
Q1
$508 Buy
26
+13
+100% +$361 ﹤0.01% 2536
2024
Q4
$402 Buy
13
+10
+333% +$274 ﹤0.01% 2339
2024
Q3
$77 Sell
3
-10
-77% -$300 ﹤0.01% 2576
2024
Q2
$381 Sell
13
-2,234
-99% -$66.3K ﹤0.01% 2365
2024
Q1
$85.5K Sell
2,247
-493
-18% -$29.6K 0.01% 410
2023
Q4
$213K Buy
2,740
+2,731
+30,344% +$169K 0.02% 283
2023
Q3
$517 Sell
9
-1,317
-99% -$68.7K ﹤0.01% 1236
2023
Q2
$68.7K Hold
1,326
0.01% 416
2023
Q1
$89.1K Buy
1,326
+1,320
+22,000% +$104K 0.01% 366
2022
Q4
$459 Buy
+6
New +$446 ﹤0.01% 1191
2022
Q2
Sell
-4
Closed -$1K 1175
2022
Q1
$1K Sell
4
-7
-64% -$882 ﹤0.01% 1017
2021
Q4
$2K Buy
+11
New +$1.7K ﹤0.01% 875

Other funds holding DAVA

Arax Advisory Partners's DAVA Position: Q2 2026 in Review

Arax Advisory Partners increased its Endava (DAVA) stake by 56,235% in Q2 2026, buying an estimated $102K and bringing the position to 27,604 shares worth $78.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2915.

Arax Advisory Partners first reported a position in DAVA in Q4 2021 and has held it in 15 quarters since. The position peaked at $213K in Q4 2023. 72 funds tracked by Wall St. Rank hold DAVA as of Q2 2026.

  • Arax Advisory Partners held 27,604 shares of Endava worth $78.1K as of Q2 2026.
  • Arax Advisory Partners bought 27,555 Endava shares in Q2 2026, an estimated $102K.
  • Endava made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2915 holding.
  • Arax Advisory Partners first reported a position in Endava in Q4 2021 and has held it in 15 quarters since.
  • Arax Advisory Partners's Endava position peaked at $213K in Q4 2023.
  • 72 funds tracked by Wall St. Rank held Endava as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.